GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ubcare Co Ltd (XKRX:032620) » Definitions » Research & Development

Ubcare Co (XKRX:032620) Research & Development : ₩1,810 Mil (TTM As of Jun. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Ubcare Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Ubcare Co's Research & Development for the three months ended in Jun. 2024 was ₩497 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was ₩1,810 Mil.

Ubcare Co Research & Development Historical Data

The historical data trend for Ubcare Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ubcare Co Research & Development Chart

Ubcare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 289.26 1,663.11

Ubcare Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 360.88 365.93 520.68 427.18 496.68

Ubcare Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,810 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ubcare Co  (XKRX:032620) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ubcare Co Research & Development Related Terms

Thank you for viewing the detailed overview of Ubcare Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Ubcare Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ubcare Co Ltd (XKRX:032620) » Definitions » Research & Development
Comparable Companies
XKRX:315640 XKRX:226330 XKRX:071200 XKRX:099750 XKRX:338220 XKRX:032850 XKRX:263700 XKRX:359090 XKRX:347700 XKRX:390110 VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH
Traded in Other Exchanges
N/A
Address
10F, 170-5, Guro3dong, Gurogu, Seoul, KOR, 152-847
Website
http://www.ubcare.net
Ubcare Co Ltd is a South Korea based company engages in the provision of healthcare solutions. It provides medical equipment, e-commerce services, and health functional foods online and offline, e-healthcare, mobile healthcare, home healthcare, and other healthcare services.

Ubcare Co Headlines

No Headlines